STAT3 and myeloproliferative disorder: Previous studies in MPN patients have demonstrated that low baseline STAT1 expression with a high fold induction upon IFNα exposure correlates with molecular response, while unchecked STAT3 activity is implicated in immune escape in other malignancies [27].